Patents by Inventor Hee Chung Kwon

Hee Chung Kwon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10760082
    Abstract: A substance inhibiting the expression of CCND3 gene or PAK2 gene, the substance containing a nucleotide such as miR-4779, may be efficiently used for preventing or treating cancer. In addition, by screening the substance that inhibits the expression of CCND3 gene or PAK2 gene, a candidate substance for preventing or treating cancer may be selected.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: September 1, 2020
    Assignee: Korea Institute of Radiological & Medical Sciences
    Inventors: Kyung Hee Koo, Hee Chung Kwon, Jie Young Song
  • Publication number: 20190256857
    Abstract: A substance inhibiting the expression of CCND3 gene or PAK2 gene, the substance containing a nucleotide such as miR-4779, may be efficiently used for preventing or treating cancer. In addition, by screening the substance that inhibits the expression of CCND3 gene or PAK2 gene, a candidate substance for preventing or treating cancer may be selected.
    Type: Application
    Filed: December 21, 2017
    Publication date: August 22, 2019
    Applicant: KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
    Inventors: Kyung Hee Koo, Hee Chung Kwon, Jie Young Song
  • Patent number: 9175288
    Abstract: Provided are a method of enhancing radiation sensitivity by using miR-499b-5p and a method of treating a radiation resistant cancer including administering miR-499b-5p.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: November 3, 2015
    Assignee: Korea Institute of Radiological & Medical Sciences
    Inventors: Hee Chung Kwon, Eun Sook Kim, Jie Young Song
  • Publication number: 20150141486
    Abstract: Provided are a method of enhancing radiation sensitivity by using miR-499b-5p and a method of treating a radiation resistant cancer including administering miR-499b-5p.
    Type: Application
    Filed: April 29, 2014
    Publication date: May 21, 2015
    Applicant: KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
    Inventors: Hee Chung KWON, Eun Sook KIM, Jie Young SONG
  • Patent number: 8318662
    Abstract: Provided are an isolated protein derived from an N-terminal of HveA/HVEM and having activity of increasing the cell infectivity of herpes simplex virus (HSV) and use thereof.
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: November 27, 2012
    Assignee: Korea Institute of Radiological & Medical Sciences
    Inventors: Hee Chung Kwon, Hyun Jung Baek, Kee Ho Lee, Masahide Kuroki
  • Publication number: 20100233758
    Abstract: Provided are an isolated protein derived from an N-terminal of HveA/HVEM and having activity of increasing the cell infectivity of herpes simplex virus (HSV) and use thereof.
    Type: Application
    Filed: March 16, 2009
    Publication date: September 16, 2010
    Applicant: KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
    Inventors: Hee Chung Kwon, Hyun Jung Baek, Kee Ho Lee, Masahide Kuroki